ArticleMethodsX2024
CaTCH: Calculating transcript complexity of human genes.
Article in MethodsX, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The findings based on whole transcriptome sequencing suggest that alternative splicing occurs in approximately 95% of human multi-exon genes, thus, playing a crucial role in promoting proteome diversity. According to the latest GENCODE annotations, most genes have less than four transcripts, positively correlating with the number of exons. Thus, it is more accurate to measure the splice variant efficiency of a gene with respect to the number of exons, which is a measure of Transcript Complexity (TC). In addition to that, the theoretical number of transcripts is substantially higher than the actual number of transcripts produced by Alternative Splicing Events, and the features restricting this phenomenon need to be explored. In this method, we have extracted the data of various features contributing to TC from different databases. Linear regression is used to identify the determinant features and to train and test the model of TC. The results indicate that exon length is the determining feature of TC, followed by coding potential, presence of chromatin signature, and 5' splice site dinucleotide, all of which negatively affect a gene's TC, except exon length. To further classify the genes based on TC, random forest is used to identify the determinant features.•The splicing efficiency of a gene can be inferred by the transcript complexity, which is the number of transcripts per exon.•CaTCH is a linear regression-based model to calculate the transcript complexity of human genes, which can be calculated from the exon length, coding potentiality, presence of chromatin signature/s, and 5' splice site dinucleotide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.